コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 pairs both CD8 T cell infiltration and acute skin graft rejection.
2 nting CBK but not third-party B10.A (H2k+Dd) skin graft rejection.
3 - T cells, however, had no influence on male skin graft rejection.
4 skin grafts; T-cell recovery correlated with skin graft rejection.
5 imulatory blockade and to inhibit allogeneic skin graft rejection.
6 D8+ T cells produce RANTES during allogeneic skin graft rejection.
7 scular injury that resembles human first-set skin graft rejection.
8 fficient class I antigen expression to cause skin graft rejection.
9 d to the CD8+ T effector cells requisite for skin graft rejection.
10 ry mediators and accelerate T cell-meditated skin graft rejection.
11 reviously recognized) features of allogeneic skin graft rejection: (1) that rejection can be initiate
14 ed T cells in a SCID reconstitution model of skin graft rejection and are important in T cell accumul
15 plore the involvement of Langerhans cells in skin graft rejection and describe fascinating results.
17 nd endothelium was examined using allogeneic skin graft rejection as a model of cutaneous inflammatio
19 his cell line specifically induced a form of skin graft rejection characterized by the presence of TH
20 no inhibition or even acceleration of donor skin graft rejection compared with non-DST control (naiv
21 od subtly yet reproducibly decreases time to skin graft rejection elicited by central but not effecto
22 G-Neutrophils, were confirmed by third-party skin graft rejection; importantly, a graft-versus-leukem
23 n to donor cells is supported by accelerated skin graft rejection in mice transplanted with sca+ cell
27 drug-modified DCs prior to transplantation, skin graft rejection kinetics were similar to those in n
28 ored by mixed lymphocyte culture (MLC), CML, skin graft rejection, liver biopsies, and serial serum c
29 ates that subsequent to T cell initiation of skin graft rejection, platelets contribute to further T
31 OVA, exhibited a somewhat delayed first set skin graft rejection response with lower allo-specific C
32 dily mounted first and second set allogeneic skin graft rejection responses, and developed primary an
33 ly unreactive in certain other assays, e.g., skin graft rejection; responses to MHC alloantigens, by
34 allopeptide can mediate a form of allogeneic skin graft rejection that exhibits characteristics of a
36 diac rejection, chronic renal rejection, and skin graft rejection were compared using CD20 or CD19 mA
37 umab (anti-CD3 mAb) and found it could delay skin graft rejection, whereas ipilimumab (anti-CTLA-4 [c
38 s was originally defined by the phenotype of skin graft rejection, which is a complex genetic trait.
39 pecific Treg cells significantly delayed CBK skin graft rejection without any other immunosuppression
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。